<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02407262</url>
  </required_header>
  <id_info>
    <org_study_id>6419/002</org_study_id>
    <nct_id>NCT02407262</nct_id>
  </id_info>
  <brief_title>Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes</brief_title>
  <official_title>Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Abdulaziz University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Traditionally, Black Seed (Nigella sativa) is a well-known food supplement and herbal product
      that has a wide range of medical claims (including asthma) that originate from different
      historical backgrounds. Today in the era of Evidence-based medicine, it is hard to accept
      those traditional medical claims of medicinal plants without valid scientific experiments.
      Thus, randomized clinical trials is important to rational the uses of herbal products.

      Asthma is a common chronic disorder of the airways, characterized by variable reversible and
      recurring symptoms related to airflow obstruction, bronchial hyper-responsiveness, and
      underlying inflammation. In Saudi Arabia, Asthma is considered one of the leading chronic
      diseases affecting more than 2 million Saudi citizens. The global Asthma Report 2014
      considered Asthma as an epidemic disease probably affecting about 334 million people
      worldwide and becoming a global health priority.

      This project investigates the use of herbal products to enhance asthma control in Saudi
      Arabia. In this context, Black Seed is one of the common herbal products used traditionally
      for asthma in the Saudi region. Black seed is a common unconventional therapy used among 10%
      of Asthmatic patients in King Abdulaziz Medical city, Riyadh. In fact, there are some
      pre-clinical evidence and preliminary clinical studies support the usefulness of Black seed
      in Asthma and its underlying causes
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma Control Test (ACT)</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum inflammatory mediators</measure>
    <time_frame>4 weeks</time_frame>
    <description>IL4, IL5, IL8, IL6, IL10, IL13, TNFa, IFN-g</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total IgE</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete blood count (CBC)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Mainly blood eosinophils</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function test (predicted FEV1%)</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Black seed oil capsules
1g/day for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (olive oil) capsules
1g/day for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Black seed oil</intervention_name>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Nigella sativa oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>vegetable oil</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male/female (age 18-65 years),

          -  asthmatic patient with Asthma Control Test (ACT) score &lt;25

          -  No severe asthma exacerbation in the last 4 weeks

          -  Able to obtain consent

        Exclusion Criteria:

          -  Patients with serious co-morbid conditions such as; cancer, renal, hepatic,
             cardio-vascular, gastrointestinal diseases, mental health conditions and respiratory
             disorder such as TB and COPD.

          -  Smoking history

          -  Pregnant women

          -  Currently taking any form of Black seed.

          -  Known history of hypersensitivity to Black seed.

          -  Taking medications that may interact with black seed supplement:
             Anticoagulant/Antiplatelet, CNS depressants, and Immunosuppressant drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Heinrich, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College, London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Abdulaziz University Hospital</name>
      <address>
        <city>Jeddah</city>
        <zip>21589</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <reference>
    <citation>Al Moamary MS. Unconventional therapy use among asthma patients in a tertiary care center in Riyadh, Saudi Arabia. Ann Thorac Med. 2008 Apr;3(2):48-51. doi: 10.4103/1817-1737.39636.</citation>
    <PMID>19561905</PMID>
  </reference>
  <reference>
    <citation>Al-Moamary MS, Alhaider SA, Al-Hajjaj MS, Al-Ghobain MO, Idrees MM, Zeitouni MO, Al-Harbi AS, Al Dabbagh MM, Al-Matar H, Alorainy HS. The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med. 2012 Oct;7(4):175-204. doi: 10.4103/1817-1737.102166.</citation>
    <PMID>23189095</PMID>
  </reference>
  <reference>
    <citation>Boskabady MH, Javan H, Sajady M, Rakhshandeh H. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients. Fundam Clin Pharmacol. 2007 Oct;21(5):559-66. Erratum in: Fundam Clin Pharmacol. 2008 Feb;22(1):105.</citation>
    <PMID>17868210</PMID>
  </reference>
  <reference>
    <citation>Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005 Dec;5(13-14):1749-70. Epub 2005 Jul 1. Review.</citation>
    <PMID>16275613</PMID>
  </reference>
  <reference>
    <citation>Lebling, R., &amp; Pepperdine, D. (2006). Natural Remedies of Arabia (p. 223). Stacey Intl.</citation>
  </reference>
  <reference>
    <citation>Salama, R. (2010). Clinical and Therapeutic Trials of Nigella Sativa. TAF Preventive Medicine Bulletin, 9(5), 513-522.</citation>
  </reference>
  <reference>
    <citation>Singh BB, Khorsan R, Vinjamury SP, Der-Martirosian C, Kizhakkeveettil A, Anderson TM. Herbal treatments of asthma: a systematic review. J Asthma. 2007 Nov;44(9):685-98. Review.</citation>
    <PMID>17994396</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2015</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College, London</investigator_affiliation>
    <investigator_full_name>Abdulrahman Koshak</investigator_full_name>
    <investigator_title>Postgraduate researcher</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>black seed</keyword>
  <keyword>Nigella sativa</keyword>
  <keyword>supplementation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

